Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for postoperative delirium after posterior lumbar fusion in older adults
ChiCTR2600132375Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Southern Medical University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in postoperative delirium (POD) (2 arms), sponsored by The Third Affiliated Hospital of Southern Medical University. Primary endpoint: Incidence of postoperative delirium within 3 days after surgery. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2600132375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132375.